miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
about
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis.MicroRNA-29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis.Mechanisms and Consequences of Oxidative Stress in Lung Disease: Therapeutic Implications for an Aging Populace.Resolution of organ fibrosis.Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells
P2860
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
@en
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
@nl
type
label
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
@en
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
@nl
prefLabel
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
@en
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
@nl
P2093
P2860
P1476
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
@en
P2093
Huachun Cui
Rui-Ming Liu
Sami Banerjee
Victor J Thannickal
P2860
P304
P356
10.1152/AJPLUNG.00335.2016
P577
2016-12-15T00:00:00Z